AssayMAP cartridge (large)

[{"image":"https://icons.cdn.biorender.com/w75xh75/5f4663665f145e0028995cd6/5f4662d45f145e0028995caf.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5f4663665f145e0028995cd6/5f4662d45f145e0028995caf.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5f4663665f145e0028995cd5/5f4662d45f145e0028995caf.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5f4663665f145e0028995cd5/5f4662d45f145e0028995caf.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5f4663665f145e0028995cd4/5f4662d45f145e0028995caf.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5f4663665f145e0028995cd4/5f4662d45f145e0028995caf.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5f4663665f145e0028995cd3/5f4662d45f145e0028995caf.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5f4663665f145e0028995cd3/5f4662d45f145e0028995caf.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5f4663665f145e0028995cd2/5f4662d45f145e0028995caf.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5f4663665f145e0028995cd2/5f4662d45f145e0028995caf.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5f4663665f145e0028995cd1/5f4662d45f145e0028995caf.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5f4663665f145e0028995cd1/5f4662d45f145e0028995caf.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5f4663665f145e0028995cd0/5f4662d45f145e0028995caf.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5f4663665f145e0028995cd0/5f4662d45f145e0028995caf.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5f4663665f145e0028995ccf/5f4662d45f145e0028995caf.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5f4663665f145e0028995ccf/5f4662d45f145e0028995caf.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5f4663665f145e0028995cce/5f4662d45f145e0028995caf.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5f4663665f145e0028995cce/5f4662d45f145e0028995caf.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5f4663665f145e0028995ccd/5f4662d45f145e0028995caf.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5f4663665f145e0028995ccd/5f4662d45f145e0028995caf.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5f4663665f145e0028995ccc/5f4662d45f145e0028995caf.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5f4663665f145e0028995ccc/5f4662d45f145e0028995caf.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5f4663665f145e0028995ccb/5f4662d45f145e0028995caf.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5f4663665f145e0028995ccb/5f4662d45f145e0028995caf.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5f4663665f145e0028995cca/5f4662d45f145e0028995caf.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5f4663665f145e0028995cca/5f4662d45f145e0028995caf.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5f4663665f145e0028995cc9/5f4662d45f145e0028995caf.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5f4663665f145e0028995cc9/5f4662d45f145e0028995caf.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5f4663665f145e0028995cc8/5f4662d45f145e0028995caf.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5f4663665f145e0028995cc8/5f4662d45f145e0028995caf.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5f4663665f145e0028995cc7/5f4662d45f145e0028995caf.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5f4663665f145e0028995cc7/5f4662d45f145e0028995caf.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5f4663665f145e0028995cc6/5f4662d45f145e0028995caf.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5f4663665f145e0028995cc6/5f4662d45f145e0028995caf.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5f4663665f145e0028995cc5/5f4662d45f145e0028995caf.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5f4663665f145e0028995cc5/5f4662d45f145e0028995caf.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5f4663665f145e0028995cc4/5f4662d45f145e0028995caf.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5f4663665f145e0028995cc4/5f4662d45f145e0028995caf.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5f4663665f145e0028995cc3/5f4662d45f145e0028995caf.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5f4663665f145e0028995cc3/5f4662d45f145e0028995caf.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5f4663665f145e0028995cc2/5f4662d45f145e0028995caf.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5f4663665f145e0028995cc2/5f4662d45f145e0028995caf.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5f4663665f145e0028995cc1/5f4662d45f145e0028995caf.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5f4663665f145e0028995cc1/5f4662d45f145e0028995caf.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5f4663665f145e0028995cc0/5f4662d45f145e0028995caf.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5f4663665f145e0028995cc0/5f4662d45f145e0028995caf.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5f4663665f145e0028995cbf/5f4662d45f145e0028995caf.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5f4663665f145e0028995cbf/5f4662d45f145e0028995caf.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5f4663665f145e0028995cbe/5f4662d45f145e0028995caf.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5f4663665f145e0028995cbe/5f4662d45f145e0028995caf.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5f4663665f145e0028995cbd/5f4662d45f145e0028995caf.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5f4663665f145e0028995cbd/5f4662d45f145e0028995caf.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5f4663665f145e0028995cbc/5f4662d45f145e0028995caf.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5f4663665f145e0028995cbc/5f4662d45f145e0028995caf.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5f4663665f145e0028995cbb/5f4662d45f145e0028995caf.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5f4663665f145e0028995cbb/5f4662d45f145e0028995caf.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5f4663665f145e0028995cba/5f4662d45f145e0028995caf.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5f4663665f145e0028995cba/5f4662d45f145e0028995caf.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5f4663665f145e0028995cb9/5f4662d45f145e0028995caf.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5f4663665f145e0028995cb9/5f4662d45f145e0028995caf.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5f4663665f145e0028995cb8/5f4662d45f145e0028995caf.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5f4663665f145e0028995cb8/5f4662d45f145e0028995caf.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5f4663665f145e0028995cb7/5f4662d45f145e0028995caf.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5f4663665f145e0028995cb7/5f4662d45f145e0028995caf.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5f4663665f145e0028995cb6/5f4662d45f145e0028995caf.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5f4663665f145e0028995cb6/5f4662d45f145e0028995caf.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5f4663665f145e0028995cb5/5f4662d45f145e0028995caf.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5f4663665f145e0028995cb5/5f4662d45f145e0028995caf.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5f4663665f145e0028995cb4/5f4662d45f145e0028995caf.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5f4663665f145e0028995cb4/5f4662d45f145e0028995caf.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5f4663665f145e0028995cb3/5f4662d45f145e0028995caf.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5f4663665f145e0028995cb3/5f4662d45f145e0028995caf.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5f4663665f145e0028995cb2/5f4662d45f145e0028995caf.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5f4663665f145e0028995cb2/5f4662d45f145e0028995caf.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5f4663665f145e0028995cb1/5f4662d45f145e0028995caf.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5f4663665f145e0028995cb1/5f4662d45f145e0028995caf.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5f4663665f145e0028995cb0/5f4662d45f145e0028995caf.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5f4663665f145e0028995cb0/5f4662d45f145e0028995caf.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5f4663745f145e0028995cd7/5f4662d45f145e0028995caf.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5f4663745f145e0028995cd7/5f4662d45f145e0028995caf.png"}]